MINNEAPOLIS, June 16 /PRNewswire/ -- ARKRAY USA, Inc. nationally launched GLUCOCARD(TM) X-METER Blood Glucose Monitoring System at the ADA (American Diabetes Association) annual meeting June 7, 2008. GLUCOCARD(TM) X-METER is well-received internationally and has been cleared by the FDA for sale in the U.S.
This intuitive system requires no coding, displays results in 5 seconds, requires a tiny 0.3 microliter sample size, and has a 360-count test memory with time and date stamp. The choice of palm, forearm, upper arm or fingertip testing, combined with the ability to reapply blood within 10 seconds if the first drop is too small (double dosing), makes testing simple and accommodating. It also features a large, easy-to-read display for better viewing of test results. The GLUCOCARD(TM) X-METER is distinguished by its leading edge design and technology. “The diabetes community has never seen such a sleek meter with all the necessary features. We have received tremendous feedback on how discreet the GLUCOCARD(TM) X-METER is. It is not your ordinary meter,” said Jonathan Chapman, President for ARKRAY USA, Inc.
About ARKRAY USA
ARKRAY has been a pioneer for nearly 50 years in the field of automated analysis from laboratory and point-of-care systems to home use patient self-testing systems. ARKRAY’s primary focus throughout that time has been diabetes. ARKRAY is the company that developed the world’s first hand held blood glucose meter (late 1960s) and the world’s first HbA1c analyzer (1982). ARKRAY is one of the few diabetes testing companies in the US market today that undertakes in-house each step of the development process to bring products to market. Worldwide, ARKRAY is the 5th largest blood glucose meter manufacturer.
Source: ARKRAY USA, Inc.
